AeroNeph Therapeutics (“AeroNeph”; www.aeronephtx.com), a pioneer in discovery of renal disease assets, has announced its MBO and corporate launch in the USA.
EpiAxis Therapeutics has announced a pioneering clinical study, showing that an epigenetic inhibitor combined with chemotherapy can treat metastatic cancer.